|
End-of-day quote
Shanghai S.E.
17/07/2026
|
5-day change
|
1st Jan Change
|
|
48.65 CNY
|
-15.11%
|
 |
-8.29%
|
-20.31%
|
|
04-29 |
Bide Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
|
CI
| |
04-21 |
Bide Pharmatech Co., Ltd. announces Annual dividend, payable on June 10, 2026
|
CI
| |
02-27 |
Bide Pharmatech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
|
CI
| |
29/10/25 |
Bide Pharmatech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
|
CI
| |
21/08/25 |
Bide Pharmatech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
|
CI
| |
31/07/25 |
Tranche Update on Bide Pharmatech Co., Ltd.'s Equity Buyback Plan announced on February 8, 2025.
|
CI
| |
29/07/25 |
Bide Pharmatech Co., Ltd.'s Equity Buyback announced on February 8, 2025, has closed with 2,176,148 shares, representing 2.48% for CNY 99.99 million.
|
CI
| |
23/04/25 |
Bide Pharmatech Co., Ltd. announces Annual dividend, payable on June 09, 2025
|
CI
| |
23/04/25 |
Bide Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
|
CI
| |
01/04/25 |
Tranche Update on Bide Pharmatech Co., Ltd.'s Equity Buyback Plan announced on February 8, 2025.
|
CI
| |
07/02/25 |
Bide Pharmatech Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.
|
CI
| |
06/02/25 |
Bide Pharmatech Co., Ltd. authorizes a Buyback Plan.
|
CI
| |
05/02/25 |
Bide Pharmatech to Issue Share to Acquire Assets
|
MT
| |
20/01/25 |
Bide Pharmatech Co., Ltd. agreed to acquire an unknown minority stake in Zhuhai Weibo Investment Co., Ltd. from Vivo Health Industry Investment Fund (Limited Partnership) managed by Vivo Capital, LLC and Vivo Equity Investment Management Co. Ltd.
|
CI
| |
14/01/25 |
Bide Pharmatech Investing $103 Million in Zhuhai Vivo Investment JV
|
MT
| |
23/10/24 |
Bide Pharmatech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024
|
CI
| |
28/08/24 |
Bide Pharmatech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024
|
CI
| |
08/07/24 |
Tranche Update on Bide Pharmatech Co., Ltd.'s Equity Buyback Plan announced on December 9, 2023.
|
CI
| |
04/07/24 |
Bide Pharmatech Co., Ltd.'s Equity Buyback announced on December 9, 2023, has closed with 2,554,024 shares, representing 2.82% for CNY 99.99 million.
|
CI
| |
02/07/24 |
Tranche Update on Bide Pharmatech Co., Ltd.'s Equity Buyback Plan announced on December 9, 2023.
|
CI
| |
25/04/24 |
Bide Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
|
CI
| |
01/04/24 |
Tranche Update on Bide Pharmatech Co., Ltd.'s Equity Buyback Plan announced on December 9, 2023.
|
CI
| |
02/02/24 |
Bide Pharmatech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
|
CI
| |
03/01/24 |
Tranche Update on Bide Pharmatech Co., Ltd.'s Equity Buyback Plan announced on December 9, 2023.
|
CI
| |
08/12/23 |
Bide Pharmatech Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.
|
CI
|
No results match your criteria Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
Choose MarketScreener 
